What are the contraindications ?

There are far fewer contraindications for Ablatherm HIFU than for other prostate cancer treatments. In fact, Ablatherm HIFU may be an excellent alternative for a patient who is contra-indicated for traditional surgery due to the presence of risk factors (cardio-vascular illness, excess weight, age, etc.). The contraindications are limited to patients who are suffering from cancer at a more advanced stage than T2c and for whom the illness is no longer confined to the prostate but has already progressed to neighbouring structures. However, this contraindication is not linked to any risk to the patient, but rather to a lower healing potential.

Ablatherm HIFU is a therapy that now has 10 years of follow-up. Because it has less follow-up than traditional techniques, it is recommended for older patients who have a life expectancy of 10 to 15 years. Nevertheless, each patient is free to choose their preferred type of treatment. In some instances, younger patients have chosen Ablatherm HIFU because they do not want to undergo complex surgical procedures or lengthy radiation treatments.